{
  "id": 7301290,
  "title": "Definium says its LSD drug notched another Phase 3 win in anxiety disorder",
  "url": "https://urgent.news/2026/09/14/definium-says-its-lsd-drug-notched-another-phase-3-win-in-anxiety",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T11:00:08.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/definiums-lsd-drug-notches-another-phase-3-win-in-anxiety-disorder/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Definium Therapeutics reported results Monday for its third Phase 3 readout this year on its oral LSD candidate, called DT120, and is gearing up for an FDA submission. The company’s late-stage data are from a ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}